You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
心脈醫療(688016.SH)業績快報:上半年歸母淨利潤2.8億元,同比增長30.18%
格隆匯 07-28 17:43

格隆匯7月28日丨心脈醫療(688016.SH)公佈2023年半年度業績快報公吿,報吿期內,公司實現營業總收入62,162.25萬元,同比增長35.49%;實現營業利潤32,696.46萬元,同比增長30.53%;實現利潤總額32,623.78萬元,同比增長30.33%;歸屬於母公司所有者的淨利潤27,992.63萬元,同比增長30.18%;歸屬於母公司所有者的扣除非經常性損益的淨利潤26,024.84萬元,同比增長27.16%;基本每股收益3.89元,同比增長30.10%。

營業總收入以及營業利潤較上年同期增長的主要原因是報吿期內公司業務規模不斷擴大,產品銷量增加導致公司銷售收入以及利潤穩步增長。公司新品Fontus分支型術中支架系統、Talos直管型胸主動脈覆膜支架系統在入院家數及終端植入量方面均實現較快增長。公司在研管線報吿期內持續推進,Cratos分支型主動脈覆膜支架及輸送系統已完成了上市前臨牀試驗最後一例患者入組。公司將繼續不斷提高公司在主動脈及外周血管介入市場的競爭力,保持快速增長趨勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account